Nantahala's $12M deal brings board influence at Femasys (NASDAQ: FEMY)

Rhea-AI Filing Summary

Femasys Inc. (FEMY) received a significant investment from funds managed by Nantahala Capital Management. On August 7, 2026, Nantahala-affiliated investors agreed to pay the company $11,999,705.22 in cash to purchase 802,145 shares of common stock, pre-funded warrants for up to 2,947,855 shares at $0.001 per share, common warrants for up to 3,750,000 shares at $2.95 per share, and milestone warrants for up to 3,750,000 shares at $2.95 per share.

As of August 10, 2026, the reporting group beneficially owned 803,038 shares, or 9.99% of Femasys’ 8,038,419 outstanding shares, reflecting warrant exercisability subject to a 9.99% Beneficial Ownership Limitation. The milestone warrants become exercisable only if Femasys reaches $1,500,000 in U.S. revenue in any fiscal quarter and the stock trades at least 130% of the exercise price for 20 of 30 consecutive trading days.

A side letter grants Nantahala governance rights for up to ten years after the purchase, including the right to designate one or two board members depending on ownership thresholds (at least 15% and 20% of outstanding shares, calculated without the ownership cap) and consent rights over specified actions such as incurring more than $2,500,000 of indebtedness. A registration rights agreement requires Femasys to file and seek effectiveness of a shelf resale registration statement covering shares issuable upon exercise of the warrants.

Key Figures

Investment Amount: $11,999,705.22 Shares Beneficially Owned: 803,038 shares Ownership Percentage: 9.99 % +5 more

8 metrics

Investment Amount $11,999,705.22 Cash paid by Nantahala Investors under the Stock Purchase Agreement on August 7, 2026

Shares Beneficially Owned 803,038 shares Beneficial ownership reported by each reporting person as of August 10, 2026

Ownership Percentage 9.99 % Percent of Femasys common stock class represented by 803,038 shares

Shares Outstanding 8,038,419 shares Shares of common stock outstanding as of August 10, 2026, including 893 issuable via warrants

Pre-Funded Warrants 2,947,855 shares at $0.001 per share Pre-Funded Warrants purchased by Nantahala Investors from Femasys

Common Warrants 3,750,000 shares at $2.95 per share Common Warrants purchased by Nantahala Investors

Milestone Warrants 3,750,000 shares at $2.95 per share Milestone Warrants, exercisable upon specified revenue and price milestones

Debt Consent Threshold $2,500,000 Level of indebtedness above which Femasys must obtain Nantahala consent under the Side Letter

Key Terms

Pre-Funded Warrants, Milestone Warrants, Beneficial Ownership Limitation, Registration Rights Agreement, +2 more

6 terms

Pre-Funded Warrants financial

"warrants to purchase up to 2,947,855 shares of Common Stock from the Issuer for $0.001 per share (the "Pre-Funded Warrants")"

Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.

Milestone Warrants financial

"contingent warrants to purchase a further 3,750,000 shares of Common Stock from the Issuer for $2.95 per share (the "Milestone Warrants")"

Milestone warrants are rights that let holders buy a company’s stock only if specific goals—such as regulatory approvals, sales targets, or project completions—are met. Think of them as a coupon that only becomes usable when the company hits agreed checkpoints; they matter to investors because they create contingent value and potential share dilution, and they signal which outcomes the company and its backers consider most important.

Beneficial Ownership Limitation regulatory

"may not be exercised if Nantahala and certain associated persons would beneficially own more than 9.99% of the Issuer's outstanding shares"

A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.

Registration Rights Agreement financial

"entered into a registration rights agreement (the "Registration Rights Agreement") with the Issuer"

A registration rights agreement is a contract that gives investors the option to have their ownership stakes officially registered with the government, making it easier to sell their shares later. This agreement matters because it provides investors with a clearer path to cash out their investments if they choose, offering more liquidity and confidence in their ability to sell their holdings when desired.

shelf resale registration statement regulatory

"prepare and file a shelf resale registration statement (the "Resale Registration Statement") with the SEC"

Side Letter financial

"Pursuant to a side letter (the "Side Letter") entered into by Nantahala and the Issuer"

FAQ

What stake in Femasys Inc. (FEMY) do the Nantahala reporting persons currently report?

The reporting persons beneficially own 803,038 shares of Femasys common stock, representing 9.99% of the 8,038,419 shares outstanding as of August 10, 2026, including shares they may acquire within 60 days through exercisable warrants.

How much did Nantahala-affiliated investors invest in Femasys Inc. (FEMY) under the Stock Purchase Agreement?

Nantahala-affiliated investors agreed to pay Femasys $11,999,705.22 in cash. In return they received 802,145 shares of common stock, pre-funded warrants for up to 2,947,855 shares, and additional warrant packages at specified exercise prices.

What are the key terms of the warrants Nantahala received from Femasys Inc. (FEMY)?

The investors received pre-funded warrants at $0.001 per share for up to 2,947,855 shares, and common and milestone warrants at an exercise price of $2.95 per share, subject to a 9.99% Beneficial Ownership Limitation on exercise.

What conditions make the Milestone Warrants in Femasys Inc. (FEMY) exercisable?

The Milestone Warrants become exercisable only if Femasys achieves $1,500,000 in U.S. revenue in any fiscal quarter and the stock trades at least 130% of the exercise price for 20 of 30 consecutive trading days.

What governance rights did Nantahala obtain in its agreement with Femasys Inc. (FEMY)?

Under a side letter, if Nantahala beneficially owns at least 15% of outstanding shares (ignoring the ownership cap), it may designate one board member; at 20%, it may designate a second. It also gains consent rights over actions like incurring debt above $2,500,000.

What registration rights did Femasys Inc. (FEMY) grant to Nantahala investors?

Femasys agreed to file a shelf resale registration statement within 30 days of the purchase to register resale of warrant shares and to use commercially reasonable efforts to have it declared effective within 60 days, subject to possible SEC comment extensions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 04:31 PM Accepted by SEC EDGAR 08/17/2026 - 04:30 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

FEMASYS INC.

(Name of Issuer)

Common Stock, $0.001 par value per share

(Title of Class of Securities)

31447E204

(CUSIP Number)

Taki Vasilakis
130 Main St. 2nd Floor,
New Canaan, CT, 06840
(203) 308-4440

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

08/10/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

schemaVersion:

SCHEDULE 13D

CUSIP Number(s): 31447E204

1

Name of reporting person

Nantahala Capital Partners Limited Partnership

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

WC

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

MASSACHUSETTS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 803,038.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 803,038.00

11

Aggregate amount beneficially owned by each reporting person

803,038.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

9.99 %

14

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13D

CUSIP Number(s): 31447E204

1

Name of reporting person

Nantahala Capital Management, LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

MASSACHUSETTS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 803,038.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 803,038.00

11

Aggregate amount beneficially owned by each reporting person

803,038.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

9.99 %

14

Type of Reporting Person (See Instructions)

IA, OO

SCHEDULE 13D

CUSIP Number(s): 31447E204

1

Name of reporting person

Wilmot B. Harkey

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 803,038.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 803,038.00

11

Aggregate amount beneficially owned by each reporting person

803,038.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

9.99 %

14

Type of Reporting Person (See Instructions)

IN, HC

SCHEDULE 13D

CUSIP Number(s): 31447E204

1

Name of reporting person

Daniel Mack

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 803,038.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 803,038.00

11

Aggregate amount beneficially owned by each reporting person

803,038.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

9.99 %

14

Type of Reporting Person (See Instructions)

IN, HC

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Stock, $0.001 par value per share
(b)	Name of Issuer: FEMASYS INC.
(c)	Address of Issuer's Principal Executive Offices: Taki Vasilakis, 130 Main St. 2nd Floor, New Canaan, CONNECTICUT , 06840.
Item 2.	Identity and Background
(a)	This Schedule 13D (this "Schedule 13D") is filed on behalf of Nantahala Capital Partners Limited Partnership, a Massachusetts limited partnership ("NCP"), Nantahala Capital Management, LLC, a Massachusetts limited liability company ("Nantahala"), Mr. Wilmot B. Harkey and Mr. Daniel Mack, the principals of Nantahala (collectively, the "Reporting Persons"). This Schedule 13D relates to common stock (the "Common Stock"), par value $0.001 per share, of Femasys Inc. (the "Issuer"), beneficially owned by Nantahala through the accounts of certain managed accounts and private funds including NCP (the "Nantahala Investors"). Nantahala serves as the General Partner, Investment Manager, or Sub-Advisor to the Nantahala Investors. Mr. Harkey and Mr. Mack are the principals and managing members of Nantahala. The Reporting Persons, other than NCP, may be deemed, pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the "Act"), to be beneficial owners all of shares of Common Stock held by the Nantahala Investors. The Reporting Persons are filing this Schedule 13D jointly, solely pursuant to Rule 13d-1(k)(1), and expressly disclaim that they form any "group" under Section 13(d)(3) of the Act. In addition, Qianqian Zhong is the Chief Financial Officer and Taki Vasilakis is the Chief Compliance Officer (each of Ms. Zhong and Mr. Vasilakis, an "Other Officer" and collectively, the "Other Officers") of Nantahala.
(b)	The principal place of business for each of the Reporting Persons and the Other Officers is 130 Main St. 2nd Floor, New Canaan, CT 06840.
(c)	The principal occupation of Mr. Harkey is serving as a principal of Nantahala. The principal occupation of Mr. Mack is serving as a principal of Nantahala. The principal business of Nantahala is acting as the investment adviser to the Nantahala Investors. The principal business of NCP is that of a hedge fund investing primarily in small and micro-cap stocks across a variety of sectors with a multi-year investment time horizon. The principal occupations of the Other Officers are the Nantahala positions set forth above.
(d)	During the last five years, none of the Reporting Persons or Other Officers has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
(e)	During the last five years, none of the Reporting Persons or Other Officers has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such proceeding, were or are subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
(f)	NCP and Nantahala are organized under the laws of the State of Massachusetts. Each of Messrs. Harkey, Mack and Vasilakis is a citizen of the United States of America. Ms. Zhong is a citizen of China.
Item 3.	Source and Amount of Funds or Other Consideration
	On August 7, 2026, the Nantahala Investors, along with other purchasers, entered into a Stock Purchase Agreement (the "SPA") with Issuer and the other purchasers signatory thereto, pursuant to which the Nantahala Investors agreed to pay the Issuer $11,999,705.22 in cash to buy 802,145 shares of Common Stock (including NCP's purchase of 221,536 shares of Common Stock), warrants to purchase up to 2,947,855 shares of Common Stock from the Issuer for $0.001 per share (the "Pre-Funded Warrants") (including NCP's purchase of Pre-Funded Warrants to purchase 814,136 shares of Common Stock), additional warrant to purchase up to 3,750,000 shares of Common Stock from the Issuer for $2.95 per share (the "Common Warrants") (including NCP's purchase of Common Warrants to purchase 1,035,672 shares of Common Stock, and contingent warrants to purchase a further 3,750,000 shares of Common Stock from the Issuer for $2.95 per share (the "Milestone Warrants" and together with the Pre-Funded Warrants and the Common Warrants, the "Warrants") (including NCP's purchase of Milestone Warrants to purchase 1,035,672 shares of Common Stock), which Milestone Warrants are not presently exercisable and shall become exercisable only upon the Company reaching certain performance milestones, all subject to customary terms and conditions. Other than the Milestone Warrants, the Warrants may be exercised immediately. The Common Warrants expire three years after issuance. The Milestone Warrants will become exercisable only upon the Issuer's achievement of both (i) U.S. revenue of at least $1,500,000 in any fiscal quarter and (ii) a volume-weighted average price of a share of Common Stock equal to or greater than 130% of the exercise price for at least 20 of the 30 consecutive trading days ending on the date of determination, and expire on the earlier of (a) three years after the effective date of the registration statement covering the shares of Common Stock issuable upon exercise of the Warrants (see Item 6 below regarding the Registration Rights Agreement) and (b) 45 days after the Issuer notifies holders of the Milestone Warrants that these milestones have been satisfied. The Warrants further provide that they may not be exercised if Nantahala and certain associated persons, including the Reporting Persons, would beneficially own more than 9.99% of the Issuer's outstanding shares of Common Stock after giving effect to such exercise (such limitation, the "Beneficial Ownership Limitation," which Beneficial Ownership Limitation may be increased by the holder of the applicable Warrant only upon 61 days advance notice to the Issuer). On August 10, 2026, the Nantahala Investors, using the cash of its existing funds and managed accounts as was on hand, consummated the transactions provided for in the SPA (the "Purchase"). Prior to the Purchase, the Reporting Persons did not beneficially own any shares of Common Stock.
Item 4.	Purpose of Transaction
	The disclosure regarding the SPA and the Purchase set forth above in Item 3 is incorporated herein by reference. The Issuer has further described the SPA, the Purchase and the Side Letter in a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the "SEC") on August 14, 2026. Pursuant to a side letter (the "Side Letter") entered into by Nantahala and the Issuer on August 7, 2026, for so long as Nantahala beneficially owns at least 15% of the outstanding shares of Common Stock (which determination shall be made without regard to the Beneficial Ownership Limitation), until the tenth anniversary of the Purchase, the board of directors (the "Board") of the Issuer shall appoint a Nantahala designee as a member of the Board (and any of its committees), subject to the reasonable agreement of the Issuer and applicable qualification requirements; Nantahala shall have the right to receive certain financial information and information presented to the Board, meet with Issuer management on a quarterly basis and be informed of certain material developments and events, subject to customary confidentiality obligations; and the Issuer shall refrain from taking certain actions without Nantahala's prior written consent, including entering into certain affiliated transactions, increasing the size of the Board, making certain terminations of, or replacing, the Issuer's chief executive officer, declaring certain dividends or distributions, incurring indebtedness in excess of $2,500,000, or adopting or seeking stockholder approval of a rights plan. During the term of the Side Letter, if Nantahala beneficially owns at least 20% of the outstanding shares of Common Stock (which determination shall be made without regard to the Beneficial Ownership Limitation, and which condition was satisfied as of immediately following the Purchase), then the Board shall appoint a second Nantahala designee as a member of the Board, subject to the reasonable agreement of the Issuer and applicable qualification requirements. The Issuer also agreed to use its commercially reasonable efforts to facilitate the voluntary resignation of two current members of the Board within sixty days after the Purchase and to certain other customary terms and conditions relating to Nantahala's designee(s) to the Board. Depending on various factors including, without limitation, the Issuer's financial position and investment strategy, the price levels of the Common Stock, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate including, without limitation, engaging in communications with the Issuer's management and Board, engaging in discussions with other Issuer investors and others about the Issuer and the Nantahala Investors' investment, making proposals to the Issuer concerning changes to the capitalization, ownership structure, Board structure (including Board composition) or operations of the Issuer, purchasing or selling additional shares of Common Stock or other Issuer securities or engaging in other transactions that may increase or decrease their interest in or economic exposure to shares of Common Stock of the Issuer or other Issuer securities, or changing their intention with respect to any and all matters referred to in Item 4. No Reporting Person has any present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D except as set forth herein or such as would occur upon or in connection with completion of, or following, any of the actions discussed herein. The Reporting Persons intend to review their investment in the Issuer on a continuing basis.
Item 5.	Interest in Securities of the Issuer
(a)	The information contained in rows 11 and 13 of each of the cover pages hereto is hereby incorporated by reference into this Item 5(a). The number of outstanding shares of Common Stock beneficially owned by each Reporting Person reflects such person's right to acquire shares of Common Stock upon exercise of the Warrants other than the Milestone Warrants, subject to the Beneficial Ownership Limitation, and in each case the percentage of the shares of Common Stock reported to beneficially owned any Reporting Person is determined on the basis of 8,038,419 shares of Common Stock outstanding as of August 10, 2026, which total includes 8,037,526 shares of Common Stock outstanding, as disclosed to the Reporting Persons by the Issuer, and an additional 893 shares of Common Stock that any Reporting Person (and all Reporting Persons together) may acquire within 60 days of the date hereof pursuant to exercise of the Warrants (subject, at all times, to the Beneficial Ownership Limitation). An increase in the number of shares of Common Stock outstanding will increase the number of shares that the Reporting Persons may acquire upon exercise of the Warrants.
(b)	The information contained in rows 7-10 of each of the cover pages hereto is hereby incorporated by reference into this Item 5(b).
(c)	Except as disclosed in Item 3, there have been no transactions in the shares of Common Stock during the past sixty (60) days by the Reporting Persons or the Other Officers.
(d)	The Nantahala Investors hold the Warrants that give rise to beneficial ownership of the shares of Common Stock reported herein. No person other than the Nantahala Investors is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Common Stock reported herein.
(e)	Not applicable.
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
	The disclosure regarding the SPA and the Side Letter set forth above in Items 3 and 4 is incorporated herein by reference. On August 7, 2026, the Nantahala Investors entered into a registration rights agreement (the "Registration Rights Agreement") with the Issuer. Pursuant to the Registration Rights Agreement, the Issuer agreed to prepare and file a shelf resale registration statement (the "Resale Registration Statement") with the SEC within 30 days of the consummation of the Purchase, for purposes of registering the resale of the shares of Common Stock issuable upon exercise of the Warrants. Under the terms of the Registration Rights Agreement, the Issuer agreed to use commercially reasonable efforts to cause the Resale Registration Statement to be declared effective by the SEC within 60 days of the date of the Purchase (which may be extended for 90 days or more in the event the SEC makes written comments to the Resale Registration Statement). The Company also agreed, among other things including customary assignment rights, to indemnify the selling stockholders from certain liabilities and to pay all fees and expenses incident to the Company's performance of or compliance with the Registration Rights Agreement. Except as disclosed above and in Item 3 and Item 4, there are no contracts, arrangements, understandings, or relationships among the Reporting Persons or Other Officers, or between any of the Reporting Persons or Other Officers and any other person, with respect to the securities of the Issuer.
Item 7.	Material to be Filed as Exhibits.
	Exhibit 99.1 Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.1 to Femasys Inc.'s Current Report on Form 8-K filed the SEC on August 11, 2026) Exhibit 99.2 Form of Common Warrant (incorporated by reference to Exhibit 4.2 to Femasys Inc.'s Current Report on Form 8-K filed the SEC on August 11, 2026) Exhibit 99.3 Form of Common Warrant (Milestone) (incorporated by reference to Exhibit 4.3 to Femasys Inc.'s Current Report on Form 8-K filed the SEC on August 11, 2026) Exhibit 99.4 Registration Rights Agreement, dated as of August 7, 2026, among Femasys Inc. and each of the several purchasers signatory thereto (incorporated by reference to Exhibit 10.2 to Femasys Inc.'s Current Report on Form 8-K filed the SEC on August 11, 2026) Exhibit 99.5 Stock Purchase Agreement, dated as of August 7, 2026, among Femasys Inc, funds affiliated with Nantahala Capital Management, LLC, and certain other investors incorporated by reference to Exhibit 10.1 to Femasys Inc.'s Current Report on Form 8-K filed the SEC on August 11, 2026) Exhibit 99.6 Side Letter, dated as of August 7, 2026, between Femasys Inc. and Nantahala Capital Management, LLC (incorporated by reference to Exhibit 10.3 to Femasys Inc.'s Current Report on Form 8-K filed the SEC on August 11, 2026) Exhibit 99.7 Joint Filing Agreement, dated August 14, 2026

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Nantahala Capital Partners Limited Partnership

Signature:	/s/ Taki Vasilakis
Name/Title:	Taki Vasilakis/Chief Compliance Officer, By its General Partner, NANTAHALA CAPITAL MANAGEMENT, LLC
Date:	08/14/2026

Nantahala Capital Management, LLC

Signature:	/s/ Taki Vasilakis
Name/Title:	Taki Vasilakis/Chief Compliance Officer
Date:	08/14/2026

Wilmot B. Harkey

Signature:	/s/ Wilmot B. Harkey
Name/Title:	Wilmot B. Harkey
Date:	08/14/2026

Daniel Mack

Signature:	/s/ Daniel Mack
Name/Title:	Daniel Mack
Date:	08/14/2026